Homozygosis for wolframin (WFS1) mutations determines Wolfram syndrome (WS), and common polymorphisms of WFS1 are associated with psychiatric illnesses and dependence behaviour. To test the influence of WFS1 polymorphisms on medication overuse headache (MOH), a chronic headache condition related to symptomatic drugs overuse, we analyzed 82 MOH patients for the WFS1 His61 lArg polymorphism, and performed a comparison between clinical features of Arg/Arg (R/R) and non-R/R individuals. Individuals harbouring the R/R genotype showed significantly higher monthly drug consumption (t= -3.504; p =0.00075) and more severe depressive symptoms on the BDI questionnaire -3.048; p = 0.003) than non-R/R. WFS1 polymorphism emerged as the only significant predictor of drug consumption, at the multivariate, regression analysis (F = 12.277; d.f. = 1,80; p = 0.00075, adjusted R-2 = 0.122). These results implicate WFS1 in the clinical picture of MOH, may be through an influence on need for drugs as in other conditions of abuse behaviour. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
The Wolframin His611Arg polimorphism infuences medication overuse headache / DI LORENZO, Cherubino; Sances, G; DI LORENZO, G; Rengo, C; Ghiotto, N; Guaschino, E; Perrotta, A; Santorelli, Fm; Grieco, Gs; Troisi, A; Siracusano, A; Pierelli, Francesco; Nappi, Giuseppe; Casali, Carlo. - In: NEUROSCIENCE LETTERS. - ISSN 0304-3940. - STAMPA. - 424:3(2007), pp. 179-184. [10.1016/j.neulet.2007.07.037]
The Wolframin His611Arg polimorphism infuences medication overuse headache
DI LORENZO, CHERUBINO;PIERELLI, Francesco;NAPPI, Giuseppe;CASALI, Carlo
2007
Abstract
Homozygosis for wolframin (WFS1) mutations determines Wolfram syndrome (WS), and common polymorphisms of WFS1 are associated with psychiatric illnesses and dependence behaviour. To test the influence of WFS1 polymorphisms on medication overuse headache (MOH), a chronic headache condition related to symptomatic drugs overuse, we analyzed 82 MOH patients for the WFS1 His61 lArg polymorphism, and performed a comparison between clinical features of Arg/Arg (R/R) and non-R/R individuals. Individuals harbouring the R/R genotype showed significantly higher monthly drug consumption (t= -3.504; p =0.00075) and more severe depressive symptoms on the BDI questionnaire -3.048; p = 0.003) than non-R/R. WFS1 polymorphism emerged as the only significant predictor of drug consumption, at the multivariate, regression analysis (F = 12.277; d.f. = 1,80; p = 0.00075, adjusted R-2 = 0.122). These results implicate WFS1 in the clinical picture of MOH, may be through an influence on need for drugs as in other conditions of abuse behaviour. (C) 2007 Elsevier Ireland Ltd. All rights reserved.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
